Visivra Official Website › Blog › Visivra Astaxanthin Dose
What is the Visivra astaxanthin dose?
The Visivra astaxanthin dose is a small number with a narrow evidence base. This page shows what the label says, the single trial that gives a comparison figure, and why that trial needs careful reading.
Quick answer
The Visivra astaxanthin dose is not published. The label names astaxanthin and prints no milligram figure. The one trial cited used 4 mg a day for 84 days, and its volunteers were children. Visivra is for adults aged 18 and over, so the trial is a yardstick, not a match.
- Astaxanthin is the fourth of six named actives, from Haematococcus pluvialis.
- Amount on the label: not printed.
- Trial dose: 4 mg a day for 84 days, which is 336 mg in total.
- The trial’s participants were children. Visivra is for adults 18 and over.
- A second trial tested it alongside anthocyanin and lutein.
See the pack and the 60-day window
The order page shows what each pack costs and the guarantee. The trial above ran 84 days, so check which pack covers that.
See today’s price and guaranteeDisclosure: Govisivra earns money when a reader orders through this button. Prices were read from the seller’s page on September 19, 2026.
What is the Visivra astaxanthin dose on the label?
There is none. The artwork lists astaxanthin as the fourth active, and the vendor tile notes that it comes from the microalga Haematococcus pluvialis. No milligram figure is printed. The bottle has no serving size and no Supplement Facts panel.
The result is a name with no number. In this category the amount is the evidence, so a name alone cannot be graded.
What dose does the single astaxanthin trial give next to the Visivra astaxanthin dose?
The record for astaxanthin in the eye is thin but real. One 2025 randomised trial gave 4 mg a day for eighty-four days and reported improvement in acute and chronic digital eye strain. That is 12 weeks. The total taken was 4 times 84, which is 336 mg.
| Item | Figure |
|---|---|
| Astaxanthin on the Visivra label | Not published |
| Dose in the 2025 trial | 4 mg a day |
| Length of the trial | 84 days (12 weeks) |
| Total taken over the trial | 336 mg |
| Who took part | Children |
| Visivra audience | Adults aged 18 and over |
The trial figures describe the study. They do not describe a Visivra capsule.
A second trial tested astaxanthin together with anthocyanin and lutein. Because the three were given as a mix, it cannot tell you what astaxanthin did alone.
Why does it matter that the trial used children when judging the Visivra astaxanthin dose?
Eyes, body weight and habits all differ between a child and an adult. A dose that suited a child tells you less about an adult dose. It does not prove a problem. It only means the study cannot answer the adult question.
The trial also had a safety result. It reported no safety signal at 4 mg a day for 84 days in children. That is reassuring for a short course. It is not the same as a long-term adult safety record.
What do marketing claims say about the Visivra astaxanthin dose?
Astaxanthin is the most heavily marketed name in this category, compared with its published record. Trade pages often quote accommodation studies. The website’s own searches could not verify those, so it does not cite them.
A claim on the seller’s information site, that the product reduces oxidative stress linked to eye fatigue, is not on the pack’s list of supports. It is not repeated here either. Our post on astaxanthin, one trial and a lot of marketing goes through this in detail.
Is there a limit on the Visivra astaxanthin dose, and how should you take it?
No upper intake limit is set. The 2025 trial reported no safety signal in children. Talk to your doctor before starting any supplement, and do not take Visivra if you are pregnant or nursing, or under 18.
Astaxanthin is fat-soluble, like lutein, zeaxanthin and vitamin A. A controlled feeding study found carotenoid absorption rose with the oil eaten alongside it. So the routine is one capsule a day with a meal that has some fat.
How long should you test a product with this Visivra astaxanthin dose?
The trial ran 84 days. Two bottles cover 60 days. Three bottles cover 90 days, which clears the trial length by 6 days. Six bottles cover 180 days.
The guarantee window is 60 days from the purchase date. So the refund window ends 24 days before a trial-length test would finish, since 84 minus 60 is 24. Think of that when you pick the pack. See the ingredients page for the other five names, and ask the order desk on +1 (323) 347-4522 for the actual astaxanthin figure.
Frequently asked questions
What is the Visivra astaxanthin dose?
It is not published. The label names astaxanthin and prints no milligram figure.
What dose did the astaxanthin trial use?
4 mg a day for 84 days, which is 336 mg in total. Its participants were children.
Is the trial result true for adults?
The study cannot say. Its volunteers were children, and Visivra is for adults aged 18 and over.
Where does the astaxanthin in Visivra come from?
The vendor tile says Haematococcus pluvialis, a microalga.
Does Visivra reduce oxidative stress from eye fatigue?
That claim appears on the seller’s information site. It is not on the pack’s list of supports, so this website does not repeat it.
Should I take astaxanthin with food?
Yes, with a meal that has some fat. Astaxanthin is fat-soluble and absorption rises with fat.
Make the test last as long as the study
Three bottles cover 90 days, six cover 180. Two cover 60, which is shorter than the 84-day trial.
Two bottles $158 · three bottles $207 · six bottles $294 · 60-day money-back guarantee
See today’s price and guaranteeDisclosure: Govisivra earns money when a reader orders through this button. Prices were read from the seller’s page on September 19, 2026.
Our view
On Visivra astaxanthin dose, our view is short. Astaxanthin has one recent trial behind it, and that trial used children. That is a real record, and a narrow one.
We would hold the Visivra astaxanthin dose to the same standard as every other blank on this label: ask for the number, and do not accept a guess. The 4 mg figure is a ruler. It is not a measurement of this capsule.
Visivra is a dietary supplement. It is not a drug and it is not FDA approved, and no supplement is. This page does not treat, cure or prevent any eye disease, and it is not medical advice. Talk to your doctor before you start a supplement, especially if you take other medicines. If your sight has changed, book an eye exam. Sudden vision loss, new floaters or flashes, or eye pain need same-day care.
Sources named on this site
Keep reading
Last updated